🇺🇸 FDA
Patent

US 8541025

Co-crystals and pharmaceutical formulations comprising the same

granted A61KA61K31/192A61K31/497

Quick answer

US patent 8541025 (Co-crystals and pharmaceutical formulations comprising the same) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/192, A61K31/497, A61K31/658, A61K45/06